NCAM1 and neoplasm: In addition, our meta-analysis that included only three trials showed CD16+ and CD56+ lymphocyte cells which would denote some of the NK cells, could combat the tumor cells and play an immunomodulatory function, inducing a Th1 immune response and improving antitumor immunoreactivity in the body [33].